Concerns Over Affordability and Counterfeit Drugs Surrounding Keytruda, a Leading Cancer Treatment
14.04.2026, 13:00
The cancer drug Keytruda, produced by Merck, has revolutionized treatment for 22 types of cancers but remains prohibitively expensive for many patients worldwide, particularly in India, where it can cost up to ₹1.5 lakh per dose. Reports indicate that high pricing and a growing demand for the drug...